Cytogenix (fka CYGX)

[downregul8]

Paulness – $30 buyout? I know it’s the weekend but I think you may be starting happy hour a little early. We’d be extremely lucky at a tenth of that – but even that won’t happen for a while. Big pharma’s typically don’t get involved until there has been some amount of human testing. Cygx is aware of this and has repeatedly indicated that they would seek help developing products in late stage trials. Since cygx knows the value of the product – enough to have net present value slides years ago – and since they know that they need to start the clinical testing before they can attract the much needed pharmaceutical partners, the question is - why is there no demonstrated sense of urgency on cygx’s part to move forward with the IND? If you believe that there is a market for these products (as I still do) then you’ve got to frustrated with the IND delays. Delays which to a great extent have been a choice.